Home/Filings/4/0001493152-23-030663
4//SEC Filing

Gleason Shane Thomas 4

Accession 0001493152-23-030663

CIK 0001433607other

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 4:15 PM ET

Size

7.3 KB

Accession

0001493152-23-030663

Insider Transaction Report

Form 4
Period: 2023-08-28
Gleason Shane Thomas
Chief Commercial Officer
Transactions
  • Award

    Options to purchase common stock (right to buy)

    2023-08-28+6,43091,910 total
    Exercise: $3.37Exp: 2033-08-28Common Stock (6,430 underlying)
  • Award

    Common Stock

    2023-08-28+19,290275,740 total
Footnotes (2)
  • [F1]These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 28, 2024, August 28, 2025 and August 28, 2026, subject to the Reporting Person's continued service.
  • [F2]The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 28, 2024, August 28, 2025 and August 28, 2026, subject to the Reporting Person's continued service.

Documents

1 file

Issuer

InspireMD, Inc.

CIK 0001433607

Entity typeother

Related Parties

1
  • filerCIK 0001966214

Filing Metadata

Form type
4
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 4:15 PM ET
Size
7.3 KB